Procter & Gamble Company (The) (PG) Earns Outperform Rating from Analysts at Macquarie

Macquarie assumed coverage on shares of Procter & Gamble Company (The) (NYSE:PG) in a research report sent to investors on Thursday, MarketBeat reports. The brokerage issued an outperform rating and a $102.00 price target on the stock.

Other analysts also recently issued research reports about the company. Vetr raised Procter & Gamble Company (The) from a buy rating to a strong-buy rating and set a $96.50 price objective on the stock in a research note on Thursday, May 18th. Zacks Investment Research downgraded Procter & Gamble Company (The) from a buy rating to a hold rating in a research note on Thursday, August 3rd. Deutsche Bank AG reaffirmed a hold rating and set a $92.00 price objective (up previously from $90.00) on shares of Procter & Gamble Company (The) in a research note on Saturday, July 22nd. BidaskClub raised Procter & Gamble Company (The) from a hold rating to a buy rating in a research note on Saturday, August 19th. Finally, Stifel Nicolaus reaffirmed a hold rating and set a $90.00 price objective (up previously from $87.00) on shares of Procter & Gamble Company (The) in a research note on Sunday, July 30th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $89.39.

Shares of Procter & Gamble Company (NYSE PG) opened at 93.27 on Thursday. Procter & Gamble Company has a 12 month low of $81.18 and a 12 month high of $94.19. The stock’s 50 day moving average price is $92.20 and its 200-day moving average price is $89.60. The firm has a market capitalization of $237.84 billion, a price-to-earnings ratio of 16.68 and a beta of 0.68.

Procter & Gamble Company (The) (NYSE:PG) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.07. Procter & Gamble Company (The) had a return on equity of 19.97% and a net margin of 23.56%. The business had revenue of $16.08 billion for the quarter, compared to analyst estimates of $16.01 billion. During the same period last year, the company earned $0.79 EPS. The firm’s revenue was down .1% on a year-over-year basis. On average, equities research analysts predict that Procter & Gamble Company will post $4.17 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Equities Focus and is the sole property of of Equities Focus. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.equitiesfocus.com/2017/09/17/procter-gamble-company-the-pg-earns-outperform-rating-from-analysts-at-macquarie.html.

In other news, insider Mark F. Biegger sold 2,660 shares of Procter & Gamble Company (The) stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $92.04, for a total value of $244,826.40. Following the completion of the sale, the insider now directly owns 23,133 shares in the company, valued at $2,129,161.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Valarie L. Sheppard sold 20,175 shares of Procter & Gamble Company (The) stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $92.65, for a total transaction of $1,869,213.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,792 shares of company stock valued at $4,216,070. Corporate insiders own 0.35% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PG. Capital Research Global Investors raised its position in shares of Procter & Gamble Company (The) by 74.2% in the second quarter. Capital Research Global Investors now owns 12,389,104 shares of the company’s stock valued at $1,079,710,000 after buying an additional 5,278,359 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Procter & Gamble Company (The) by 1,244.6% in the second quarter. Janus Henderson Group PLC now owns 4,500,564 shares of the company’s stock valued at $392,226,000 after buying an additional 4,165,862 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Procter & Gamble Company (The) by 2.3% in the second quarter. Vanguard Group Inc. now owns 180,730,770 shares of the company’s stock valued at $15,750,688,000 after buying an additional 4,066,266 shares in the last quarter. BlackRock Inc. raised its position in shares of Procter & Gamble Company (The) by 1.4% in the second quarter. BlackRock Inc. now owns 156,361,011 shares of the company’s stock valued at $13,626,862,000 after buying an additional 2,164,426 shares in the last quarter. Finally, Parametric Portfolio Associates LLC raised its position in shares of Procter & Gamble Company (The) by 30.6% in the second quarter. Parametric Portfolio Associates LLC now owns 6,349,258 shares of the company’s stock valued at $553,334,000 after buying an additional 1,487,095 shares in the last quarter. Institutional investors own 59.33% of the company’s stock.

About Procter & Gamble Company (The)

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Analyst Recommendations for Procter & Gamble Company (The) (NYSE:PG)

Receive News & Ratings for Procter & Gamble Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply